Concepedia

Publication | Open Access

Real-world experience of emicizumab prophylaxis in young children with hemophilia A: retrospective data from China

32

Citations

14

References

2022

Year

Abstract

Emicizumab could reduce bleeds in pediatric patients with/without FVIII inhibitors and eliminate target joints.

References

YearCitations

Page 1